4CPS-037 Analysis of usage profile, effectiveness and safety of alirocumab in a tertiary hospital

BackgroundHypercholesterolaemia is a common and growing health problem, above all in developed countries, which can cause serious consequencies in patients who suffer from it. Alirocumab is a monoclonal antibody that blocks a protein called PCSK9 and prevents LDL cholesterol receptors being absorbed...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2018-03, Vol.25 (Suppl 1), p.A58-A58
Hauptverfasser:	Garcia, C Mondelo, Bargiela, N Fernández, Olivera, C Fernández, Filgueiras, J Balea, Arufe, V Giménez, Herranz, MI Martín
Format:	Artikel
Sprache:	eng
Schlagworte:	Cholesterol Clinical trials Low density lipoprotein Monoclonal antibodies Section 4: Clinical pharmacy services Statins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!